DUBLIN, May 20, 2015 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/w2bmfh/european_markets) has announced the addition of the "European Markets for Soft Tissue Reinforcement and Regeneration - 2015" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
The European market for soft tissue reinforcement and regeneration differs substantially from the U.S. market; the European adoption rate of biologics is significantly lower than that of the United States. Since biologic matrices are often significantly more expensive than their synthetic counterparts in Europe, the low biologic adoption rate has a substantial negative impact on the soft tissue market as a whole. Due to the strictly evidence-based approach throughout Europe, the benefits of biologic products, such as expedited healing and reduced likelihoods of graft rejection, are not seen to outweigh their high costs.
The European market for soft tissue reinforcement and regeneration includes graft devices that are designed to reinforce and regenerate soft tissues. Soft tissues are defined as aggregations of similarly specialized cells which collectively function to connect, support or surround other structures and organs of the body. These tissues include tendons, ligaments, fascia, skin, fibrous tissues, fat, synovial membranes, muscles, nerves and blood vessels. Collagen, the most abundant protein in mammals, is one of the characteristic elements inside the extracellular matrix of soft tissue and, as such, plays a critical role in soft tissue repair.
Because soft tissue essentially makes up the majority of a person, and there are countless medical conditions associated with soft tissue problems, a select group of large markets related to soft tissue repair will be covered in this report, including breast reconstruction, hernia repair, dural repair, vaginal slings, skin repair, sports medicine and tendon reinforcement, and dental soft tissue regeneration. These indications were selected because they feature the use of synthetic mesh and biological matrices to reinforce and regenerate deficient areas.
There are three primary classes of soft tissue reinforcement and regeneration devices: allografts, xenografts, and alloplasts.
Key Topics Covered:
1. Executive Summary
2. Research Methodology
3. Europe Soft Tissue Reinforcement And Regeneration Market Overview
4. Country Profiles
5. Procedure Numbers
6. Breast Reconstruction Market
7. Hernia Repair Market
8. Dural Repair Market
9. Vaginal Sling Market
10. Skin Repair Market
11. Sports Medicine And Tendon Reinforcement Market
12. Dental Soft Tissue Regeneration Market
13. Appendix I: Procedure Numbers
14. Appendix II: Breast Reconstruction Market
15. Appendix III: Hernia Repair Market
16. Appendix IV: Dural Repair Market
17. Appendix V: Vaginal Sling Market
18. Appendix VI: Skin Repair Market
19. Appendix VII: Sports Medicine And Tendon Reinforcement Market
20. Appendix VIII: Dental Soft Tissue Regeneration Market
21. Appendix IX: U.K. Pelvic Floor Reconstruction Market
22. Abbreviations
Companies Mentioned
- Aesculap/B.Braun
- American Medical Systems
- Baxter/Synovis
- Boston Scientific
- Botiss
- C.R. Bard
- Coloplast
- Cook Medical
- Covidien
- Depuy Synthes
- Ethicon
- Geistlich
- Integra LifeSciences
- LifeCell
- Lowmann & Rauscher
- Medskin Solutions
- Novus Scientific
- PFM Medical
- Serag-Wiessner
- Smith & Nephew
- Stryker
- Systagenix
- Tornier
- Tutogen
For more information visit http://www.researchandmarkets.com/research/w2bmfh/european_markets
Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net
